LEUKEMIA & LYMPHOMA SOCIETY DARETODREAM PROJECT Trademark

Trademark Overview


On Monday, May 23, 2022, a trademark application was filed for LEUKEMIA & LYMPHOMA SOCIETY DARETODREAM PROJECT with the United States Patent and Trademark Office. The USPTO has given the LEUKEMIA & LYMPHOMA SOCIETY DARETODREAM PROJECT trademark a serial number of 97423792. The federal status of this trademark filing is EX PARTE APPEAL PENDING as of Tuesday, November 14, 2023. This trademark is owned by The Leukemia & Lymphoma Society, Inc.. The LEUKEMIA & LYMPHOMA SOCIETY DARETODREAM PROJECT trademark is filed in the Advertising, Business and Retail Services, Insurance & Financial Services, Education & Entertainment Services, Computer & Software Services & Scientific Services, Medical & Beauty Services & Agricultural Services, Personal, and Legal & Social Services categories with the following description:

Providing patient education services in the nature of classes, courses, and workshops in the field of cancer

Accepting and administering monetary charitable contributions in the field of cancer; medical research services in the field of cancer, namely, providing financial sponsoring for clinical trials

Promoting the interests of cancer patients and medical professionals in the field of cancer by means of public advocacy; promoting public awareness of cancer by means of public advocacy

Providing personal support services for patients and families of patients with cancer, namely, emotional counseling and emotional support in the field of cancer

Providing medical counseling and information about medical terms and clinical trials to patients, families, and healthcare providers in the field of cancer, including helping children, patients, caregivers, parents and physicians to identify appropriate clinical trials for children with cancer; providing information in the field of cancer treatment; providing nutritional consultations to patients, families, and caregivers in the field of cancer

Conducting clinical trials in the nature of medical research in the field of cancer; consulting services for others, namely, helping others design, plan, implement, and manage clinical trials in the field of cancer
leukemia & lymphoma society daretodream project

General Information


Serial Number97423792
Word MarkLEUKEMIA & LYMPHOMA SOCIETY DARETODREAM PROJECT
Filing DateMonday, May 23, 2022
Status760 - EX PARTE APPEAL PENDING
Status DateTuesday, November 14, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesProviding patient education services in the nature of classes, courses, and workshops in the field of cancer
Description of MarkThe mark consists of a red drop design to the left of the wording "LEUKEMIA & LYMPHOMA SOCIETY" in grey, followed by a grey vertical line; to the right of the vertical line is the wording "DARETODREAM PROJECT" with "DARE" and "DREAM" in red and "TO" and "PROJECT" in grey, and a red star design in the upper right.
Pseudo MarkLEUKEMIA AND LYMPHOMA SOCIETY DARE TO DREAM PROJECT
Goods and ServicesAccepting and administering monetary charitable contributions in the field of cancer; medical research services in the field of cancer, namely, providing financial sponsoring for clinical trials
Section 2(f) Limitation Statement"LEUKEMIA & LYMPHOMA SOCIETY" has become distinctive of the goods/services through the applicant's substantially exclusive and continuous use of the mark in commerce that the U.S. Congress may lawfully regulate for at least the five years immediately before the date of this statement; "LEUKEMIA & LYMPHOMA SOCIETY" has become distinctive of the goods/services as evidenced by the ownership on the Principal Register for the same mark for sufficiently similar goods/services of active U.S. Registration No(s). 5531343, 5531342, 5150184, 5098957, and 4132890
Indication of Colors claimedThe color(s) red and grey is/are claimed as a feature of the mark.
Goods and ServicesPromoting the interests of cancer patients and medical professionals in the field of cancer by means of public advocacy; promoting public awareness of cancer by means of public advocacy
Goods and ServicesProviding personal support services for patients and families of patients with cancer, namely, emotional counseling and emotional support in the field of cancer
Goods and ServicesProviding medical counseling and information about medical terms and clinical trials to patients, families, and healthcare providers in the field of cancer, including helping children, patients, caregivers, parents and physicians to identify appropriate clinical trials for children with cancer; providing information in the field of cancer treatment; providing nutritional consultations to patients, families, and caregivers in the field of cancer
Disclaimer with Predetermined Text"SOCIETY"
Goods and ServicesConducting clinical trials in the nature of medical research in the field of cancer; consulting services for others, namely, helping others design, plan, implement, and manage clinical trials in the field of cancer

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, May 26, 2022
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, May 26, 2022
Primary Code036
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateThursday, May 26, 2022
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, May 26, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, May 26, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, May 26, 2022
Primary Code045
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameThe Leukemia & Lymphoma Society, Inc.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressRye Brook, NY 10573

Trademark Events


Event DateEvent Description
Wednesday, November 15, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 15, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 14, 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, November 14, 2023EX PARTE APPEAL-INSTITUTED
Tuesday, November 14, 2023JURISDICTION RESTORED TO EXAMINING ATTORNEY
Tuesday, November 14, 2023EXPARTE APPEAL RECEIVED AT TTAB
Monday, August 14, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, August 14, 2023FINAL REFUSAL E-MAILED
Monday, August 14, 2023FINAL REFUSAL WRITTEN
Monday, July 10, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 10, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 10, 2023ASSIGNED TO LIE
Wednesday, March 8, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 9, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 9, 2022NON-FINAL ACTION E-MAILED
Friday, December 9, 2022NON-FINAL ACTION WRITTEN
Thursday, December 8, 2022ASSIGNED TO EXAMINER
Friday, May 27, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, May 26, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 26, 2022NEW APPLICATION ENTERED